StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultAug 13, 2026, 04:54 PM

IM Cannabis Q2 Revenue $7.6M, Net Loss $4.4M; H1 Net Loss $6.9M

AI Summary

IM Cannabis Corp. announced its financial results for the second quarter and first half of 2026, reporting significant declines across key metrics. For Q2 2026, revenue fell to $7.6 million from $12.7 million year-over-year, and the net loss expanded to $4.4 million. The first half of 2026 also saw revenue drop to $16.3 million from $25.2 million, with a net loss of $6.9 million. The company's cash position decreased to $1.6 million, and it reported a shareholders' deficit of $5.5 million.

Key Highlights

  • Q2 2026 revenue decreased to $7.6 million from $12.7 million in Q2 2025.
  • Q2 2026 net loss widened to $4.4 million, or $0.47 per share, from $0.2 million in Q2 2025.
  • H1 2026 revenue was $16.3 million, down from $25.2 million in H1 2025.
  • H1 2026 net loss increased to $6.9 million, or $0.85 per share, from $0.02 million in H1 2025.
  • Cash balance as of June 30, 2026, was $1.6 million, down from $2.7 million at Dec 31, 2025.
  • Total assets stood at $24.7 million, with total liabilities at $30.3 million.
  • Shareholders' deficit attributable to the company was $5.5 million.